
Excelsoft Technologies IPO Listing at 12.5% Premium at ₹135 Per Share
Posted by : sachet | Wed Nov 26 2025

Excelsoft Technologies IPO listing: The Excelsoft Technologies IPO was subscribed 45.46 times till its closing. In this subscription, qualified institutional buyers (QIBs) received 107.04 times, and non-institutional investors (NIIs) received 107.04 times. The retail quota of the issue was subscribed to 35.00%. Before delving deeper into the topic, go through the details of the Excelsoft Technologies IPO.
Excelsoft Technologies IPO
It is a book-building issue of 500.00 crore shares, comprising a fresh issue of 1.50 crore shares and an offer-for-sale of 2.67 crore shares. The IPO is expected to be listed on the BSE and NSE, with a tentative listing date of 26th November 2025. The Excelsoft Technologies IPO is scheduled to take place from 19th November 2025 to 21st November 2025. The face value of Excelsoft Technologies IPO shares is ₹1 per share, and the IPO price is set at ₹114 to ₹120 per share.
| IPO Open Date | 19th November 2025 |
| IPO Close Date | 21st November 2025 |
| IPO Allotment Date | 24th November 2025 |
| Refund Initiation | 25th November 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹114 to ₹120 per share |
| Lot Size | 125 Shares |
| Issue Size | 4,16,66,666 shares(aggregating up to ₹500.00 Cr) |
| Fresh Issue | 1,50,00,000 shares(aggregating up to ₹180.00 Cr) |
| Offer for sale | 2,66,66,666 shares of ₹10(aggregating up to ₹320.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE and NSE |
| Listing Date | 20th November 2025 |
Excelsoft Technologies IPO Listing
On the NSE and BSE platforms, Excelsoft Technologies shares are listed at ₹135 per share, reflecting a 12.5% premium over the issue price of ₹120 per share.
About the Excelsoft Technologies IPO Listing
Excelsoft Technologies Limited was founded in 2000 and is a vertical SaaS company with expertise in the learning and assessment market. The company provides AI-powered applications, test and assessment platforms, online proctoring solutions, learning experience platforms, student success platforms, and digital eBook platforms.
The company’s SARAS LMS, including EnablED LXP and OpenPage digital books, offer tailored learning support for academic institutions and corporations, addressing their training, learning, and development needs.
- Expertise in product engineering, development and implementation across assessments, digital learning & information management systems with robust product capabilities.
- Long-term relationships with global customers.
- Expertise in delivering fully compliant digital learning and assessment solutions to clients globally.
- Flexibility to work with diversified technologies to provide the right-fit solution, driven by agile methodologies.
- Robust Operating Parameters.
- Experienced Management Team and Promoters with expertise in developing products.
Excelsoft Technologies Limited Financials
The company’s financial analysis is essential before applying for Excelsoft Technologies Limited’s IPO. Refer to the table to learn about Excelsoft Technologies Limited’s financial information.
| Year Ended | 30th June 2025 | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
| Assets | 478.34 | 470.49 | 421.03 | 436.13 |
| Revenue | 60.28 | 248.80 | 200.70 | 197.97 |
| Profit After Tax | 6.01 | 34.69 | 12.75 | 22.41 |
| EBITDA | 10.18 | 73.26 | 54.97 | 68.18 |
| Net Worth | 375.95 | 371.29 | 297.30 | 278.08 |
| Reserve and Surplus | 274.25 | 269.66 | 295.71 | 276.48 |
| Total Borrowing | 37.82 | 26.59 | 76.73 | 118.09 |
Explanation
Excelsoft Technologies Limited’s revenue increased by 24% from ₹200.70 crore in March 2024 to ₹248.80 crore in March 2025. Moreover, the company’s PAT increased by 172% from ₹12.75 crores to ₹34.69 crores. Investors can analyse other relevant factors and make a decision accordingly.
Recent Articles
Best Penny Stocks for Long Term in India | Penny Stocks in 2025
Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to ₹314.63 Crore; Revenue Surged 3.55% YoY
Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to ₹35.34 Crore; Revenue Jumps 4.74% YoY
Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to ₹154.38 Crore; Revenue Up 9.54% YoY

